NCT03951389View on ClinicalTrials.gov

INST 1204: PIK3CA Mutations as Biomarkers for Metastasis in Colon Cancer

CompletedOBSERVATIONAL
Enrollment

750

Participants

Timeline

Start Date

May 22, 2012

Primary Completion Date

October 21, 2019

Study Completion Date

October 21, 2019

Conditions
Colon Cancer
Interventions
OTHER

Non-interventional

Non-interventional

Trial Locations (1)

87131

University of New Mexico Comprehensive Cancer Center, Albuquerque

All Listed Sponsors
lead

New Mexico Cancer Research Alliance

OTHER

NCT03951389 - INST 1204: PIK3CA Mutations as Biomarkers for Metastasis in Colon Cancer | Biotech Hunter | Biotech Hunter